Search For "alzheimer disease"
Updated : 2 weeks, 4 days ago IST
Researchers have identified a biomarker that could help physicians diagnose Alzheimer's disease earlier.
Updated : 1 month ago IST
The study found the benefits of crossword puzzles in improving memory functioning in older adults.
Updated : 1 month, 1 week ago IST
Washington [US], October 17 (ANI): Researchers at UVA Health have identified a brain chemical that coordinates the immune system's reactions to multiple sclerosis (MS) and Alzheimer's disease, potentially enabling medical professionals to boost the body's capacity to combat these and other d
Updated : 1 month, 3 weeks ago IST
Sapporo [Japan], October 7 (ANI): Researchers have devised a way to identify amyloid build-up in the brain, a symptom of Alzheimer's disease, using biomarkers found in blood samples.
Updated : 1 month, 4 weeks ago IST
Washington [US], September 30 (ANI): Researchers have used artificial intelligence to predict hospitalisation outcomes of geriatric patients with dementia on the first or second day of admission. Early outcome assessment means more timely interventions, better care coordination, more prudent
Updated : 2 months, 3 weeks ago IST
Houston [US], September 8 (ANI): A recently created agonistic antibody reduced amyloid pathology in mice with Alzheimer's disease, indicating its potential as a therapy for the condition, according to the researchers.
Updated : 3 months, 1 week ago IST
Washington [US], August 21 (ANI): According to a new MIT study, Alzheimer's disease impacts at least one form of visual memory by deteriorating a recently discovered circuit that connects the image processing areas of each brain hemisphere.
Washington [US], August 19 (ANI): Alzheimer's disease affects at least one type of visual memory by deteriorating a recently found circuit that connects the image processing areas of each brain hemisphere, according to a new MIT study.
Updated : 3 months, 3 weeks ago IST
Daejeon [South Korea], August 4 (ANI): The US Food and Drug Administration recently approved Aduhelm, a monoclonal antibody that targets amyloid beta (A), as the first Alzheimer's disease treatment (AD). Its impact on cognitive improvement, however, is controversial.
Daejeon [South Korea], August 4 (ANI): Aduhelm, a monoclonal antibody that targets amyloid beta (A), was recently found by the US Food and Drug Administration as the first treatment for Alzheimer's disease (AD). However, its impact on cognitive improvement is still debatable.
Updated : 5 months, 1 week ago IST
London [UK], June 20 (ANI): During new research, researchers used a machine learning technology to look into the structural features within the brain, including the areas which were not previously associated with Alzheimer's.
Updated : 2 years, 3 months ago IST
Washington D.C. [USA], August 2 (ANI): Dozens of molecules may tangle up with rogue bundles of tau, a protein that normally gives nerve fiber structure to cause brain cell damage that contributes to neurodegenerative diseases, according to a recent study.